viernes, 24 de febrero de 2017

Ivanhoe's Top 5 Reports This Week

Give the gift of health news!
Click here to sign up your friends and loved ones for the 

First to Know Newsletter!

Smart Living for this week:

Clearing Space On Your iPhone

Grandparents Get Geeky

Paid Maternity Leave Still Rare In U.S.

Preventable Household Dangers


Doctor's In-depth Interview of the week

Stem Cells Treat Baldness with PRP - In-Depth Doctor Interview


Quote of the week:

“We take freedom for granted, and because of this we don't understand how incredibly vulnerable it is.” 

— Niall Ferguson


Website Information:

Content Licensing:

RALEIGH, N.C. (Ivanhoe Newswire) — Breast milk is often called “liquid gold” for its health and nutritional benefits to infants. And now researchers are finding it has an especially big impact on a baby’s gut microbiome. This is what researchers found when they compared exclusively breast fed babies to those who were fed a combination of breast milk and formula

PITTSBURGH, Pa. (Ivanhoe Newswire) — Every year, surgeons use balloons and stents to open the arteries of nearly one million Americans. For about ten percent of those patients, the arteries will re-narrow meaning additional procedures. In some cases, doctors are using a small dose of a common cancer treatment to keep those arteries clear.

BALTIMORE, Md. (Ivanhoe Newswire) — Researchers say they now have evidence that too much of a good thing can possibly damage your heart. The results of a new study suggest that calcium supplements may raise the risk of plaque buildup in arteries.

CHICAGO. (Ivanhoe Newswire) — Osteoarthritis is the most common form of arthritis in the U.S., affecting nearly 27 million adults. It is currently an incurable disease in which the joints deteriorate. Now, a therapy that has been used in eye surgery and to heal the skin of burn victims is being used for the first time in knees. This new form of treatment involves stem cells from amniotic fluid.

LOS ANGELES. (Ivanhoe Newswire) — Americans spend between one and four billion dollars a year treating hair loss. Now, four surgeons in the U.S. are testing a stem cell treatment in a non-surgical procedure. Overseas trials in Japan and Egypt are already showing some success.

No hay comentarios:

Publicar un comentario